My Cart {{InsertCartProduct}}
Subtotal: {{TotalProductAmt}}.00
Dr. Madhur D. Shastri is one of the founders of Immanence Pharmaceuticals and is functioning as President of Health/Medical Research and Innovation. Dr. Shastri holds Bachelor of Pharmacy from the Rajiv Gandhi Proudyogiki Vishwavidyalaya (Indore, India) and Master’s in Pharmaceutical Sciences from the University of Tasmania(Tasmania, Australia). His interest in health and medical research led him to obtain PhD in Pharmaceutical and Pharmacological Sciences from the University of Tasmania, Australia.
Dr. Shastri worked as a biomedical scientist and developed his research profile in the areas of respiratory disorders, gastrointestinal diseases, smoking cessation, drug discovery and delivery, physicochemical stability of antibiotics, therapeutic drug targets, marine drugs, anti-inflammatory and anti-cancer properties of natural compounds and complex polysaccharides, gut microbiomeand functional foods. Dr. Shastri has so far published 60 scientific articles, obtained $7,00,000 in fellowship and grants for his research, and has established numerous worldwide collaborations with clinicians, practitioners, scientists and researchers to conduct and deliver high-quality research outcomes.
Dr. Shastri has on-going research interests in Medicinal Plants Research in the maintenance of health and/or in the prevention, diagnosis, improvement or treatment of various diseases. He believes in the application of traditional herbal medicines, as plants were man’s only chemist in ancient times.Dr Shastri is committed to research dissemination and community engagement to ensure that novel findings impact policy and practice, and research is accessible to end-users. At Immanence, he is leading extensive research operations and holds responsibility for the development and implementation of innovative strategies, policies, and systems to achieve strategic goals of Immanence Pharmaceuticals in research and innovation.
Mr. Neeraj Kumar Singh is the Founder and President of Operations and International Business of the Company. Mr. Singh is a Biomedical Scientist and has done MSc from Cambridge, UK. He also has done MPhil from Australia and his PhD is due to complete by 2022.
Mr. Singh worked as a Scientist in various clinical trials in Australia before pioneering Immanence Pharmaceuticals Pvt. Ltd. He has published numerous research papers and exhibited his research work in several scientific conferences including Australian Society of Microbiology scientific meetings and Australian Vaccines and Immunotherapeutic meetings.
Mr. Singh has played a key role in successfully brewing and shaping Immanence Pharmaceuticals Pvt. Ltd. and directing ambitions with strategic acquisitions. Mr. Singh has established a top-class leadership team for the Company as it continues to expand its wings globally. As a President Operations and International Business, he focuses on Board and operation matters including Immanence’s strategic priorities through corporate culture, hiring right talent, and public advocacy.
Mr. Amar Raghuvanshi is co-founder of Immanence Pharmaceuticals and acting as President of Finance, Sales and Marketing. Mr. Raghuvanshi completed Company Secretary degree and LLB from India.
He worked as a company secretary for several years before coming together to root the Immanence Pharmaceuticals Private Limited. He has taken active roles in managing the finance of the company and provide leadership and oversight of the company’s marketing strategies to produce finest outcomes and impact.
Mr. Raghuvanshi has extensive experience in sales, marketing and finance and played active role in promoting new products, overseeing sales and marketing of the company. He has launched many products and helped them grow in brands. He was instrumental in achieving all the targets set by management and his key strengths are target centric approach and self-discipline. At Immanence, he focuses on organisational proficiency, cost effectiveness, analytics, automation, and better governance. Mr. Raghuvanshi plays a key role to establish and foster strategies in commercialisation, intellectual property, industry and business engagement, and will develop strategic partnerships with agencies, alliances and external partners to enhance the planned objectives of the company.
